Picture of Biotech Growth Trust logo

BIOG Biotech Growth Trust Income Statement

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedMid Cap

Annual income statement for Biotech Growth Trust, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue-24.126.766226-207
Cost of Revenue
Gross Profit-28.821.861.7201-201
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses5.455.384.8624.9-5.02
Operating Profit-29.521.361.1201-202
Net Income Before Taxes-29.521.361.1201-202
Provision for Income Taxes
Net Income After Taxes-29.821.160.9200-202
Net Income Before Extraordinary Items
Net Income-29.821.160.9200-202
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-29.821.160.9200-202
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.5330.3881.355-4.88

Or unlock with your email

Or unlock with your email